Form 4: Paul Stuka Acquires 87,500 Shares of InspireMD, Inc. at $1.3827 per Share

Director Paul Stuka acquired 87,500 shares of InspireMD, Inc. at $1.3827 per share on June 5, 2024, while also reporting beneficial ownership of securities held by Osiris Investment Partners, L.P.

Summary

• On June 5, 2024, Paul Stuka, a director of InspireMD, Inc., acquired 87,500 shares of common stock at a price of $1.3827 per share.
• Following this transaction, Stuka directly owns 311,548 shares of InspireMD, Inc.
• Stuka also reported indirect beneficial ownership of 336,034 shares held by Osiris Investment Partners, L.P.
• He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
• The report also mentions a Series H Warrant (right to buy) for 87,500 shares at $1.3827, expiring on June 26, 2024, held indirectly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard Form 4 filing indicating a director's stock purchase, which can be interpreted as a positive sign, but it's not overwhelmingly positive.

Positives

• The director's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The transaction could potentially influence shareholder perception of the company's prospects.

Key Dates